Dali Pharmaceutical Co (SHSE:603963) 3-Year Book Growth Rate : -6.80% (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Dali Pharmaceutical Co 3-Year Book Growth Rate?

Dali Pharmaceutical Co's Book Value per Share for the quarter that ended in Mar. 2024 was ¥1.71.

During the past 12 months, Dali Pharmaceutical Co's average Book Value per Share Growth Rate was -5.70% per year. During the past 3 years, the average Book Value per Share Growth Rate was -6.80% per year. During the past 5 years, the average Book Value per Share Growth Rate was -4.40% per year. During the past 10 years, the average Book Value per Share Growth Rate was -0.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 12 years, the highest 3-Year average Book Value per Share Growth Rate of Dali Pharmaceutical Co was 18.30% per year. The lowest was -18.10% per year. And the median was -3.40% per year.

Competitive Comparison of Dali Pharmaceutical Co's 3-Year Book Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Dali Pharmaceutical Co's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dali Pharmaceutical Co's 3-Year Book Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dali Pharmaceutical Co's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Dali Pharmaceutical Co's 3-Year Book Growth Rate falls into.

Dali Pharmaceutical Co 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

Dali Pharmaceutical Co (SHSE:603963) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

Dali Pharmaceutical Co 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Dali Pharmaceutical Co's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Dali Pharmaceutical Co (SHSE:603963) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dali Pharmaceutical Co Ltd (SHSE:603963) » Definitions » 3-Year Book Growth Rate

Traded in Other Exchanges

N/A

Address

No. 118, Huancheng West Road, Yunnan Province, Xiaguan Town, Dali, CHN, 671000

Website

http://www.daliyaoye.cn

Dali Pharmaceutical Co Ltd operates in the pharmaceutical manufacturing industry. It is engaged in the research and development and production of Chinese and Western medicine injection products. The company's main products are Zhongjing Brand Xingnaojing Injection, Shenmai Injection, Astragalus Injection, Brighten A Injection and Cell Diphosphocholine injection.

Executives

Wu Pei Rong	senior management
Yang Jun Xiang	Directors, senior managers
Yang Jun Wei	Director

Dali Pharmaceutical Co (SHSE:603963) Headlines

No Headlines